Virtus ETF Advisers LLC Sutro Biopharma, Inc. Transaction History

Virtus ETF Advisers LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.41 - $8.95 $36,384 - $95,496	-10,670 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.78 - $15.31 $4,940 - $9,721	-635 Reduced 5.62%	10,670 $88,000
Q4 2021 Feb 14, 2022	BUY	$14.25 - $23.53 $3,391 - $5,600	238 Added 2.15%	11,305 $168,000
Q3 2021 Nov 15, 2021	SELL	$16.88 - $22.38 $9,739 - $12,913	-577 Reduced 4.96%	11,067 $209,000
Q2 2021 Aug 10, 2021	SELL	$18.03 - $23.82 $39,089 - $51,641	-2,168 Reduced 15.7%	11,644 $216,000
Q1 2021 May 17, 2021	BUY	$20.29 - $27.54 $4,788 - $6,499	236 Added 1.74%	13,812 $314,000
Q4 2020 Feb 12, 2021	BUY	$10.16 - $23.98 $137,932 - $325,552	13,576 New	13,576 $295,000

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $131M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.